Classifications

• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
  • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
  • C07D498/14—Ortho-condensed systems
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K31/00—Medicinal preparations containing organic active ingredients
  • A61K31/33—Heterocyclic compounds
  • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
  • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
  • A61K31/5375—1,4-Oxazines, e.g. morpholine
  • A61K31/5383—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with heterocyclic ring systems
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K31/00—Medicinal preparations containing organic active ingredients
  • A61K31/33—Heterocyclic compounds
  • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
  • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
  • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
  • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P25/00—Drugs for disorders of the nervous system
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P25/00—Drugs for disorders of the nervous system
  • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P3/00—Drugs for disorders of the metabolism
  • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
  • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P35/00—Antineoplastic agents
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P35/00—Antineoplastic agents
  • A61P35/02—Antineoplastic agents specific for leukemia
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P35/00—Antineoplastic agents
  • A61P35/04—Antineoplastic agents specific for metastasis
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P37/00—Drugs for immunological or allergic disorders
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
  • C07D513/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains three hetero rings
  • C07D513/14—Ortho-condensed systems
• • G—PHYSICS
  • G01—MEASURING; TESTING
  • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
  • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
  • G01N21/75—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated
  • G01N21/76—Chemiluminescence; Bioluminescence
  • G01N21/763—Bioluminescence

Landscapes

• Health & Medical Sciences (AREA)
• Chemical & Material Sciences (AREA)
• Organic Chemistry (AREA)
• Life Sciences & Earth Sciences (AREA)
• General Health & Medical Sciences (AREA)
• Veterinary Medicine (AREA)
• Pharmacology & Pharmacy (AREA)
• Medicinal Chemistry (AREA)
• Animal Behavior & Ethology (AREA)
• Public Health (AREA)
• Chemical Kinetics & Catalysis (AREA)
• Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
• General Chemical & Material Sciences (AREA)
• Engineering & Computer Science (AREA)
• Bioinformatics & Cheminformatics (AREA)
• Epidemiology (AREA)
• Immunology (AREA)
• Oncology (AREA)
• Hematology (AREA)
• Neurology (AREA)
• Neurosurgery (AREA)
• Biomedical Technology (AREA)
• Diabetes (AREA)
• Physics & Mathematics (AREA)
• Emergency Medicine (AREA)
• Obesity (AREA)
• Psychiatry (AREA)
• Endocrinology (AREA)
• Plasma & Fusion (AREA)
• Analytical Chemistry (AREA)
• Biochemistry (AREA)
• General Physics & Mathematics (AREA)
• Pathology (AREA)
• Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
• Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
• Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
• Nitrogen Condensed Heterocyclic Rings (AREA)

Applications Claiming Priority (3)

Publications (1)

Family

ID=63490700

Family Applications (2)

Family Applications After (1)

Country Status (16)

Families Citing this family (17)

Family Cites Families (36)

• 2018
  • 2018-08-22 CN CN201880067225.5A patent/CN111511748B/zh active Active
  • 2018-08-22 CA CA3073445A patent/CA3073445A1/en active Pending
  • 2018-08-22 WO PCT/US2018/047444 patent/WO2019040573A1/en not_active Ceased
  • 2018-08-22 ES ES18765259T patent/ES2971457T3/es active Active
  • 2018-08-22 AU AU2018321496A patent/AU2018321496B2/en active Active
  • 2018-08-22 CN CN202310267471.8A patent/CN116425771A/zh active Pending
  • 2018-08-22 KR KR1020207008179A patent/KR102680163B1/ko active Active
  • 2018-08-22 EP EP18765259.9A patent/EP3672976B1/en active Active
  • 2018-08-22 EP EP18765254.0A patent/EP3672975B1/en active Active
  • 2018-08-22 JP JP2020510610A patent/JP7467332B2/ja active Active
  • 2018-08-22 FI FIEP18765259.9T patent/FI3672976T3/fi active
  • 2018-08-22 DK DK18765254.0T patent/DK3672975T3/da active
  • 2018-08-22 FI FIEP18765254.0T patent/FI3672975T3/fi active
  • 2018-08-22 KR KR1020207008178A patent/KR102705861B1/ko active Active
  • 2018-08-22 JP JP2020510576A patent/JP7467331B2/ja active Active
  • 2018-08-22 SG SG11202001553UA patent/SG11202001553UA/en unknown
  • 2018-08-22 DK DK18765259.9T patent/DK3672976T3/da active
  • 2018-08-22 NZ NZ762503A patent/NZ762503A/en unknown
  • 2018-08-22 MX MX2020002032A patent/MX2020002032A/es unknown
  • 2018-08-22 MX MX2020002033A patent/MX2020002033A/es unknown
  • 2018-08-22 EP EP23167453.2A patent/EP4227311A1/en active Pending
  • 2018-08-22 CN CN201880067185.4A patent/CN111448198B/zh active Active
  • 2018-08-22 IL IL272762A patent/IL272762B2/en unknown
  • 2018-08-22 CA CA3073446A patent/CA3073446A1/en active Pending
  • 2018-08-22 AU AU2018322059A patent/AU2018322059C1/en active Active
  • 2018-08-22 WO PCT/US2018/047411 patent/WO2019040550A1/en not_active Ceased
  • 2018-08-22 CN CN202310439771.XA patent/CN116621860A/zh active Pending
  • 2018-08-22 ES ES18765254T patent/ES2948287T3/es active Active
• 2020
  • 2020-02-20 US US16/795,720 patent/US11365206B2/en active Active
  • 2020-02-20 US US16/795,884 patent/US11279711B2/en active Active
  • 2020-02-28 ZA ZA2020/01301A patent/ZA202001301B/en unknown
• 2022
  • 2022-03-18 US US17/698,289 patent/US11680072B2/en active Active
  • 2022-06-15 US US17/840,957 patent/US11993610B2/en active Active
• 2023
  • 2023-05-03 US US18/142,842 patent/US12410190B2/en active Active
• 2024
  • 2024-04-22 US US18/641,869 patent/US20240425520A1/en not_active Abandoned
  • 2024-12-06 US US18/971,214 patent/US20250179090A1/en active Pending

Also Published As

Similar Documents